Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BKTI - Adjusted earnings (if you go for that sort of thing) were 19 cents this quarter. They did say on the cc that they were talking about $1.50 gaap eps for 2024. They do have the low 3.5M share count which will be highly beneficial when converting earnings to eps. I guess we will see if they are accurate with their forecast. Q1 results aren't far away.
BKTI - $13 + $1.50, Listened to the conference call this morning. Company is forecasting GAAP earnings of $1.50 for 2024. Company is selling more of their higher margin BKR9000 radios and is currently transitioning to outsourcing their manufacturing.
AAOI is going to sell some stock:
Item 1.01. Entry into a Material Definitive Agreement.
On March 13, 2024, Applied Optoelectronics, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”) with Raymond James & Associates, Inc. (the “Sales Agent”) pursuant to which the Company may issue and sell shares of the Company’s common stock, par value $0.001 per share (the “Shares”) having an aggregate offering price of up to $25 million from time to time through the Sales Agent.
Upon delivery of a placement notice and subject to the terms and conditions of the Agreement, sales, if any, of the Shares will be made through the Sales Agent in transactions that are deemed to be “at the market” offerings as defined in Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), including sales made through the facilities of the Nasdaq Global Market, the principal trading market for the Company’s common stock, on any other existing trading market for the Company’s common stock, to or through a market maker or as otherwise agreed by the Company and the Sales Agent. In the placement notice, the Company will designate the maximum number of Shares to be sold through the Sales Agent, the time period during which sales are requested to be made, the minimum price for the Shares to be sold, and any limitation on the number of Shares that may be sold in any one day. Subject to the terms and conditions of the Agreement, the Sales Agent will use its commercially reasonable efforts to sell Shares on the Company’s behalf up to the designated amount specified in the placement notice. The Company has no obligation to sell any Shares under the Agreement and may at any time suspend offers and sales of the Shares under the Agreement.
The Agreement provides that the Sales Agent will be entitled to compensation of up to 2% of the gross sales price of the Shares sold through the Sales Agent from time to time. The Company has also agreed to reimburse the Sales Agent for certain specified expenses in connection with the registration of Shares under state blue sky laws and any filing with, and clearance of the offering by, the Financial Industry Regulatory Authority Inc., not to exceed $10,000 in the aggregate, and any associated application fees incurred. Additionally, if the Agreement is terminated under certain circumstances, and the Company fails to sell a minimum amount of the Shares as set forth in the Agreement, then the Company has agreed to reimburse the Sales Agent for reasonable out-of-pocket expenses, including the reasonable fees and disbursements of counsel incurred by the Sales Agent, up to a maximum of $30,000 in the aggregate. The Company agreed to indemnify the Sales Agent against certain liabilities, including liabilities under the Securities Act, or to contribute to payments that the Sales Agent may be required to make because of any of those liabilities.
The offering pursuant to the Agreement will terminate upon the sale of all Shares subject to the Agreement. The Agreement may also be terminated by the Company or by the Sales Agent at any time.
The Shares to be issued and sold have been registered under the Securities Act, pursuant to the Company’s shelf registration statement on Form S-3 (Registration No. 333-269132) (the “Registration Statement”), which was declared effective by the Securities and Exchange Commission on March 21, 2023, including the prospectus contained therein, as supplemented by the prospectus supplement filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act on March?13, 2024.
The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the Agreement, which is filed as Exhibit 1.1 to this Current Report on Form 8-K and incorporated herein by reference.
HRTG - Gotta love the analysts:
Heritage Insurance downgraded to Market Perform at JMP Securities
The Fly - Mar 13 04:48 EDT
JMP Securities analyst Matthew Carletti downgraded Heritage Insurance to Market Perform from Outperform without a price target. The shares have meaningfully surpassed the firm's previous $7 price target and are now fairly valued, the analyst tells investors in a research note. The firm says that despite Heritage's recent capital raise, its excess capital is limited, and therefore, its growth will be as well.
Heritage Insurance price target raised by $2 at Truist, here's why
The Fly - Mar 13 09:28 EDT
Truist raised the firm's price target on Heritage Insurance to $11 from $9 and keeps a Buy rating on the shares after its Q4 earnings beat. The company's actions addressing rate adequacy over the past two years are now being reflected in the financial statements, the analyst tells investors in a research note. Heritage Insurance also touched on the company's strategic reduction of its multi-state personal lines polices-in-force to manage reinsurance costs and improve the overall quality of the book as they focus on rate adequacy and selective geographic growth, the firm added.
ARC - I joined you. Hard to resist with that big yield. This one seems to jump around a little bit, so I wouldn't be too surprised to see it move back up towards the $3 area.
ELTK - I'm in at $10.60 or so. Will be tuning into the conference call.
Congrats on the homebuilders, researcher. KBH, LEN, and TOL all hitting new 52-week highs today.
In other news, DKS also hitting a new 52-week high today, and BGFV in the toilet after giving lousy guidance and cutting their dividend again.
ARC - Bummer on the site remediation. That's probably the last time they will acquire a property that formerly held a gas station! Hopefully they are now fully reserved for that.
I'm staying put, also. I was bidding on some shares yesterday after hours but didn't get any. It's a nice yield and like you said the outlook is pretty good, so I don't see any reason to sell here.
I hit one every now and again. Lots of geniuses in a bull market......
VLCN - I guess I should have stuck with that one a bit longer. These low floaters are wild ones!
SGRP - The CEO usually sounds pretty optimistic, but I don't remember any statement quite like this one. They started exploring strategic alternatives in September of 2022, and it is an ongoing process according to yesterday's press release. Here is the original announcement:
SGRP - I found today's press release interesting. The last line is a pretty bold statement:
SPAR Group Sells Interest in China Joint Venture
GlobeNewswire - Feb 27 10:30 EDT
Company continues to simplify operations and structure
AUBURN HILLS, Mich., Feb. 27, 2024 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR”, “SPAR Group” or the “Company”), a leading global provider of merchandising, marketing and distribution services, reports the sale of its ownership interest in SPAR China, the joint venture based in Shanghai. Terms were not released.
“As we continue to evaluate strategic alternatives for the business, we are simplifying our operating and financial structure. At the same time, we are focused on building our core business that has experienced strong demand and growth over the last three years,” said Mike Matacunas, President and CEO, SPAR Group.
“Our core-owned U.S. business has experienced 50%+ growth and our Canada business has grown by more than 90% in this time period. We are pleased with these results and will build upon this momentum. This is a good time to invest in SPAR Group.”
AWX - Good question. I know I would have been selling every last share.
AWX - Looking back, the doctor owned 167k shares in 1999. He's been adding through the years. He's been buying shares for 25 years!
I didn't know this previously, but AWX was a spinoff of American Waste Services in 1998. They do own quite a bit of real estate including three golf courses and a hotel. Chances are good that their tangible book value of around $9.50 a share is understated with the rise in real estate values over the years. Here is a list of their properties:
VLCN - I'm out as of today. Got stopped out. Stock just isn't acting right. Or maybe it is acting right, since it is a money-losing piece of junk! The only redeeming quality is its ultra-low float, and I'm beginning to question if that is accurate.
It did trade up into the 1.50s in the premarket since I bought it, but I was snoozing and didn't take advantage. Maybe it will rocket to $3 tomorrow or keep plunging. Anyone's guess, but I'm out.
VLCN - Retreated a bit. I think with a tiny float of 135k shares, this thing could rocket to $7 or more. It's a junk stock, but momentum traders could definitely have their way with it.
VLCN - Looks like she may be ready to blow!
Short Warren Buffet video about the difficulty of analyzing financial companies. The question comes from a young Bill Ackman I think.
https://www.google.com/search?client=firefox-b-1-d&q=warren+buffett+some+companies+are+too+hard+to+analyze#fpstate=ive&vld=cid:56ff9b0f,vid:5mOs4SRYwco,st:0
PLSDF - Another nice report for them. I really like the fact that even though they are based in Canada, they put out their earnings reports through normal channels for the U.S. investors.
VLCN - LJ, are you trying to say anyone who invests in this company will soon be in Schitt's Creek without a paddle? Is that the gist of it?
VLCN $1.10, Here is an extremely speculative stock. Volcon, Inc. develops, manufactures, and sells electric off road powersport vehicles. The only thing uglier than their balance sheet is their income statement. Either one is a scary sight. A secondary offering or a bankruptcy filing could be right around the corner.
They did a 1-for-45 reverse split earlier this month. The price has been sliding ever since. There are now only 1.2M shares outstanding. The entire market cap is $1.3M The float totals 135k. I bought a small position at $1.07 today. I think this thing could shoot off like a rocket in this highly speculative environment. Definitely not one to buy with embezzled funds.
TSLA - Oh, okay. I'm disabused. I thought it was a certainty from your post.
TSLA - Well, heck, if that's the case, you should put all your money in TSLA and start vacationing now.
ARC - I bought some recently. Great yield and steady earnings.
FORD - I had a small position that I dumped this morning. I don't like the deterioration of their balance sheet with their continuing losses, although this blurb from the 10-Q shows that they should be okay for awhile since their largest creditor, Forward China, is working with them.
CTHR - No, I didn't listen to the conference call. I did just now read the exchange between the CEO and Paul Johnson that you referenced. That's funny and not funny all at the same time. Another lousy quarter.
I was talking to my daughter yesterday about their business. She told me that the moissanite and lab grown diamonds are very popular these days with her age group ( early 20s). She also told me that she was seeing those type of rings all over tik tok and various other places. After speaking with her, I'm wondering if the competition is eating away their market share.
The balance sheet still looks great, but they can't continue losing money like they are currently. I'm holding on for now since it is still so cheap, but I may change my mind if they have to start melting down the inventory!
CSPI - Lots of good news rolling in lately. You have been a true believer in this company for a long time, and it has been paying off nicely. Earnings tomorrow morning.
DBGI - It's the low float of 792k shares that's enabling this thing to soar. It reverse split 1:25 last August.
Hweb - I guess it makes perfect sense in the wonderful world of accounting. Constant currency reporting is a non-gaap thing. Truthfully, a bit confusing to me.
So from what I read, I take it that the constant currency number for this quarter was calculated using the currency exchange rate from the prior year's quarter. Exchange rates are always going to be changing, so I don't really know how much attention we should pay to the constant currency number. Apparently the market is looking at the guidance and pretty much ignoring the constant currency number.
NTWK - Picked some up in the $2.50s. Seems like things are finally turning around for them. Tangible book value over $2 a share. Strong balance sheet. Reported earnings this morning, and future looks bright according to the CEO:
[quote“We are very pleased with our second quarter results and continue to strategically invest and allocate capital to further expand our presence across key, high growth markets like North America. Given our recent results and trajectory, we expect to see strong double digit organic revenue growth and improved margins throughout the second half of fiscal 2024 as we move into a period of more sustainable profitability.”
][/quote]
Full release:
https://www.globenewswire.com/news-release/2024/02/13/2828249/15855/en/NETSOL-Technologies-Reports-23-Revenue-Growth-and-EPS-of-0-04-in-Fiscal-Second-Quarter-2024.html
CSPI - I just sold the last of what I bought today. I think today's announcement is a big feather in the cap for them, but I don't want to hold into earnings at the new high.
BELFB - What a monster run. Congrats. Isn't that the truth. The larger the position, the sweatier the palms! Good luck whichever way you go.
NYCB - Very nice price recovery. There was a bullish writeup on SA over the weekend, also. I bought some shares on Friday after JS016 made a timely post regarding the insider buys.
https://seekingalpha.com/article/4669376-a-hard-look-at-new-york-community-bancorp-after-a-60-percent-drop
CSPI - Point well taken. This stock is a wild, no clothes on swinger likely to indulge in excess today!
CSPI - This sounds like the breakthrough deal for their cybersecurity solution.
CSPI - World-Leading Pharmaceuticals Company Secures Global Manufacturing Assets Using Breakthrough ARIA Cybersecurity Solution
Accesswire - Feb 12 08:30 EDT
Top 5 pharmaceutical in a multi-million dollar deal deploys AZT PROTECT to protect critical assets from cyberattack
BOSTON, MA / ACCESSWIRE / February 12, 2024 / ARIA Cybersecurity Solutions, a CSPi business (NASDAQ:CSPi), announced today that one of the world's largest pharmaceutical manufacturers has selected ARIA Cybersecurity's AZT PROTECT™ solution to protect its critical infrastructure from a new wave of sophisticated cyberattack. The US-based multinational corporation, a Fortune-500 company with billions of dollars in annual revenue, in a multi-million dollar deal will deploy AZT PROTECT across its global manufacturing, protecting over 40 facilities in response to the growing cybersecurity threat to operational technology (OT) from hostile nation states, terrorism, and organized cybercrime.
AZT PROTECT is the first-of-its-kind solution developed to protect OT environments from attacks such as those inflicted on Merck, WestRock, Clorox, and the SolarWinds attacks that impacted thousands of companies across its supply chain. The pharmaceutical industry is particularly vulnerable to sophisticated cyberattacks that are proven to bypass existing cyber defenses. Such an attack on the industry would have far-reaching financial, reputational, and regulatory consequences, and could even impact patient access to important medicines.
Unlike leading next-generation antivirus (NGAV) and endpoint detection response (EDR) solutions, AZT PROTECT is custom-built for OT environments, offering protection against the most advanced zero-day and supply chain attacks, without the need for continuous cloud updates resulting in weekly production downtime interruptions to apply updates and patches. AZT PROTECT neutralizes attacks in real time as they try and execute in device memory, stopping the attacks before they cause harm. It leverages a patented AI-driven technique to continuously analyze executable code, scripts, and processes.
To learn more about how AZT PROTECT protects pharmaceutical manufacturers, please watch our latest webinar at: https://info.ariacybersecurity.com/webinar-safeguard-ot-environments
Launched in July 2023, AZT PROTECT is being deployed in industrial settings that use OT to manage physical infrastructure supporting functions such as R&D, manufacturing, and distribution. A major Fortune-500 chemical manufacturer recently rolled out AZT PROTECT to protect its critical production applications. The solution is also being deployed by a major western intelligence agency to protect its critical intelligence gathering and analysis operations from cyberattack. [WA1]
"A cyberattack on a pharmaceutical's facility could lead to theft of intellectual property, compromised safety and quality, regulatory fines, and major disruption to manufacturing processes. And yet many companies in the industry are ill-prepared to protect their critical assets from a new wave of cyberthreat that can bypass network-based protections and modern cloud-based NGAV solutions," says Gary Southwell, General Manager of ARIA Cybersecurity. "This new contract with one of the world's largest pharmaceutical companies to deploy AZT PROTECT is another endorsement for our breakthrough approach to OT cybersecurity that protects critical production environments from all forms of attack, including those never seen before."
ABOUT ARIA CYBERSECURITY SOLUTIONS
ARIA Cybersecurity Solutions, a business of CSPi Inc., recognizes that better, stronger, more effective cybersecurity starts with a smarter approach. Our solutions provide new ways for organizations to protect their most critical assets-they can shield their critical applications from attack with our AZT solution, while monitoring internal traffic, device-level logs, and alert output with our ARIA ADR solution to substantially improve threat detection and surgically disrupt cyberattacks and data exfiltration. Customers in a range of industries rely on our solutions to accelerate incident response, automate breach detection, and protect their most critical assets and applications-no matter where they are stored, used, or accessed. Learn more at ARIACybersecurity.com.
CONTACT:
ARIA Cybersecurity Media Contact
Gary Southwell
info@ariacybersecurity.com
SOURCE: CSP Inc.
SRTS - I agree that there must have been something that happened with their largest customer that caused their sales to drop off a cliff in Q1 2023.
2022 Q1 Total Sales: $10.34M (largest customer $8.37M) - all other sales: $1.96M
2023 Q1 Total Sales: $3.41M (largest customer $2.05M) - all other sales: $1.36M
Sales to their largest customer dropped a whopping 76 percent.
Sales to all others dropped 31 percent.
They sure didn't give any guidance during the conference call, which makes me not want to hold any into their next earnings report. In addition, like you noted, they had abnormally low operating expenses this quarter. Maybe they are back on track. Who knows. There was this bullet point in their press release that seemed encouraging on its face:
SRTS - Sensus Healthcare price target raised by $3.50 at Alliance Global Partners, here's why
The Fly - Feb 09 09:40 EDT
Alliance Global Partners analyst Ben Haynor raised the firm's price target on Sensus Healthcare to $7.50 from $4 and keeps a Buy rating on the shares. Sensus reported Q4 results above the firm's estimates, and the company did an "admirable" job controlling operating expenses, the analyst tells investors in a research note. The big news was the announcement the company has launched a recurring revenue model, which the firm thinks will favorably alter perception even though the economics may not significantly impact the company until 2025 and beyond, the firm said.
GRRR - Yup, it's the earnings and traders love to trade this low-priced stuff with lots of volume.
Nelson, I'm out of town, so........
I did read something the other day, though. Accredited investors are supposed to be able to make trades on the expert market, but the mainstream brokers aren't even allowing that to happen. You will definitely want to triple check this, but I read it somewhere.